Patent details

Basic Information

Publication number:

EP2922877

PCT Application Number:

US2013071067

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP138572698

PCT Publication Number:

WO2014081864

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

IMPROVED PEPTIDE PHARMACEUTICALS

French Title of Invention:

AGENTS PHARMACEUTIQUES PEPTIDIQUES AMÉLIORÉS

German Title of Invention:

VERBESSERTE PEPTIDARZNEIMITTEL

SPC Number:

Dates

Filing date:

20/11/2013

Grant date:

05/09/2018

EP Publication Date:

30/09/2015

PCT Publication Date:

30/05/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/09/2018

EP B1 Publication Date:

05/09/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

20/11/2018

Expiration date:

20/11/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/08/2018

 

 

Name:

Eumederis Pharmaceuticals, Inc.

Address:

12707 High Bluff Drive, Suite 200, San Diego, CA 92130, United States (US)

Inventor

Name:

NESTOR, John, J.

Address:

United States (US)

Priority

Priority Number:

201261728667 P

Priority Date:

20/11/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/00; A61K 38/07; A61K 38/08; A61K 38/26; A61K 38/29; C07K 1/107; C07K 5/065; C07K 7/06; C07K 19/00; C09D 101/28;

Publication

European Patent Bulletin

Issue number:

201836

Publication date:

05/09/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/03/2019	Outgoing Correspondence	1